Patient Monitoring Devices – Market Insights – United States

The US market for patient monitoring devices will experience modest growth over the forecast period, driven by the home care, neurological and hemodynamic monitoring device markets. Noninvasive hemodynamic monitoring devices are the fastest growing segment in the patient monitoring device market, and will thus be vital in determining growth for competitors in this sector.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for patient monitoring devices in the US from 2019 through 2033.

The pulse oximeter segment generates a sizable proportion of revenue in the US patient monitoring device market.

What is the current market size of the pulse oximeter segment in the US?

Who were the market leaders in 2023, and what were their leading products?

Government regulations and technological advancements will bolster the patient monitoring device market.

How are these factors driving the market for patient monitoring devices?

Which segments are seeing the strongest growth?

Which device segment represents the largest share of patient monitoring device revenues?

Efforts to reduce readmission and hospital-acquired infection rates in the US will play a major role in patient monitoring device selection.

How are concerns over readmission penalties and hospital-acquired infections impacting patient monitoring device selection in the US?

Which specific market segments within the patient monitoring device industry are most vulnerable to the impact of readmission penalties and hospital-acquired infections?

What measures are device manufacturers taking to ensure their products remain attractive to the US hospitals?

Less invasive methods of patient monitoring will increasingly replace invasive techniques in response to the denial of reimbursement for cases of hospital-acquired infections.

To what extent will each market segment be affected by these shifts in monitoring techniques?

How will the preference for less invasive methods drive product adoption in the patient monitoring device market?

What influence will physicians’ preferences have on the utilization of invasive techniques?

How can establish device manufacturers without experience in patient monitoring take advantage of high-growth market segments?

Will innovations in the market cause system prices to fluctuate over the forecast period?

Market share dynamics are being affected by mergers and acquisitions.

What recent mergers and acquisitions have affected the competitive landscape of this market?

How will the portfolios of the major competitors change?